ESTA
Get informed when a big investor buys or sells
+ FollowOvervalued by 226.8% based on the discounted cash flow analysis.
| Market cap | $1.81 Billion |
|---|---|
| Enterprise Value | $1.75 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.72 |
| Beta | 1.06 |
| Outstanding Shares | 30,121,685 |
| P/E Ratio | -47.14 |
|---|---|
| PEG | 161.44 |
| Price to Sales | 7.67 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 7.1 |
| Enterprise Value to EBIT | -85.54 |
| Enterprise Value to Net Income | -45 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.09 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 56.81% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.05%▼ 93.38% |
|---|---|
| Total Invested | $973,844▼ 99.96% |
| Investors Holding | 4▼ 206.00% |
No data
Establishment Labs Holdings Inc. is a global medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfoli...